Fidelity Investments
WINT

Fidelity Investments’s Windtree Therapeutics Inc WINT Stock Holding History

Fidelity Investments’s Portfolio WINT Stock Details WINT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-224,091
Closed -$278K – 2754
2016
Q4 		$278K Hold
224,091
– – ﹤0.01% 2595
2016
Q3 		$575K Sell
224,091
-2,400
-1% -$5.22K ﹤0.01% 2530
2016
Q2 		$438K Sell
226,491
-20,657
-8% -$49.9K ﹤0.01% 2565
2016
Q1 		$408K Buy
247,148
+1,056
+0.4% +$2.27K ﹤0.01% 2569
2015
Q4 		$737K Sell
246,092
-674,837
-73% -$2.77M ﹤0.01% 2561
2015
Q3 		$3.87M Buy
920,929
+5,700
+0.6% +$37.7K ﹤0.01% 2254
2015
Q2 		$8.71M Buy
915,229
+899
+0.1% +$12.6K ﹤0.01% 2068
2015
Q1 		$15.2M Hold
914,330
– – ﹤0.01% 1846
2014
Q4 		$14.8M Buy
914,330
+1,402
+0.2% +$30.8K ﹤0.01% 1859
2014
Q3 		$23.5M Buy
912,928
+1,654
+0.2% +$39.9K ﹤0.01% 1672
2014
Q2 		$22.7M Buy
911,274
+3,807
+0.4% +$97.3K ﹤0.01% 1739
2014
Q1 		$27.3M Buy
907,467
+42,876
+5% +$1.44M ﹤0.01% 1620
2013
Q4 		$27.2M Buy
864,591
+277,967
+47% +$8.69M ﹤0.01% 1587
2013
Q3 		$16.1M Buy
586,624
+1,889
+0.3% +$45.8K ﹤0.01% 1774
2013
Q2 		$12.4M Buy
+584,735
New +$14.4M ﹤0.01% 1864

Other funds holding WINT

BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
ARTA
A.R.T. Advisors New York $1.79M AUM 57.47% 1-Year Est. Return

Fidelity Investments's WINT Position: Q1 2017 in Review

Fidelity Investments sold out of Windtree Therapeutics Inc (WINT) in Q1 2017, closing a stake of 224,091 shares — an estimated $278K sold.

Fidelity Investments first reported a position in WINT in Q2 2013 and held it in 15 quarters. The position peaked at $27.3M in Q1 2014. 26 funds tracked by Wall St. Rank hold WINT as of Q1 2017.

  • Fidelity Investments reported no remaining Windtree Therapeutics Inc position as of Q1 2017 after selling out during the quarter.
  • Fidelity Investments sold 224,091 Windtree Therapeutics Inc shares in Q1 2017, an estimated $278K.
  • Fidelity Investments first reported a position in Windtree Therapeutics Inc in Q2 2013 and held it in 15 quarters.
  • Fidelity Investments's Windtree Therapeutics Inc position peaked at $27.3M in Q1 2014.
  • 26 funds tracked by Wall St. Rank held Windtree Therapeutics Inc as of Q1 2017.

Based on Fidelity Investments's 13F filing for Q1 2017, filed 11 May 2017.